Last reviewed · How we verify

NCT05424341

Effects Of Muscle Energy Versus Counter Strain Technique on Pain, Function and Satisfaction Level in Planter Fasciitis

Completed NA Last updated 7 April 2023
What this trial tests

NA trial testing Muscle Energy Technique in Plantar Fasciitis in 66 participants. Completed in 1 December 2022.

Timeline
1 June 2022
Primary endpoint
1 December 2022
1 December 2022

Quick facts

Lead sponsorUniversity of Lahore
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment66
Start date1 June 2022
Primary completion1 December 2022
Estimated completion1 December 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

University of Lahore

Who can join

Adults 20 to 68, any sex, with Plantar Fasciitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Previous studies has discussed the effects of muscle energy technique and counterstrain technique in upper trapezius and low back pain but no comparative study is found on planter fasciitis patients. In this study we are going to compare the effects of muscle energy technique and counterstrain technique with routine physical therapy in relation with pain, functional status and satisfaction level in planter fasciitis patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Muscle Energy Technique

Trials testing the same drug.

Other recruiting trials for Plantar Fasciitis

Currently open trials in the same condition.

Other University of Lahore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05424341.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing